Trials / Completed
CompletedNCT03558373
The Adherence of Immunosuppressive Therapy Including Tacrolimus Once-daily in Italian Kidney Transplant Recipients
The Adherence of Immunosuppressive Therapy Including Tacrolimus Once Daily in a Cohort of Kidney Transplant Recipients: an Italian Prospective Observational Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 158 (actual)
- Sponsor
- Chiesi Farmaceutici S.p.A. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Non-adherence is widespread in the transplant community. Addressing issues associated with non-adherence remains a key challenge in transplantation, in part due to the difficulty in assessing its prevalence, as there is currently no 'gold standard' for use in routine clinical practice. The purpose of this study is to evaluate the non-adherence to immunosuppressive therapy, including tacrolimus once-daily, among Italian kidney transplant recipients receiving. Along with non-adherence evaluation, possible factors related to NA will be investigated (patient-related, condition/disease-related, therapy/treatment-related, etc.).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Immunosuppressive | Immunosuppressive therapies |
Timeline
- Start date
- 2018-07-31
- Primary completion
- 2020-02-26
- Completion
- 2020-02-26
- First posted
- 2018-06-15
- Last updated
- 2022-05-05
Locations
12 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT03558373. Inclusion in this directory is not an endorsement.